At the time of writing, Alto Neuroscience Inc. [ANRO] stock is trading at $14.11, up 7.14%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ANRO shares have gain 10.15% over the last week, with a monthly amount glided 55.05%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Alto Neuroscience Inc. [NYSE: ANRO] stock has seen the most recent analyst activity on September 03, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $29. On February 27, 2024, TD Cowen initiated with a Outperform rating. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $32 on February 27, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $32 as its price target on February 27, 2024. Jefferies started tracking with a Buy rating for this stock on February 27, 2024, and assigned it a price target of $33.
For the past year, the stock price of Alto Neuroscience Inc. fluctuated between $7.91 and $24.00. Currently, Wall Street analysts expect the stock to reach $32 within the next 12 months. Alto Neuroscience Inc. [NYSE: ANRO] shares were valued at $14.11 at the most recent close of the market. An investor can expect a potential return of 126.79% based on the average ANRO price forecast.
Analyzing the ANRO fundamentals
Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -145.73%, Pretax Profit Margin comes in at -133.88%, and Net Profit Margin reading is -133.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.83 and Total Capital is -0.29. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.12 points at the first support level, and at 12.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.83, and for the 2nd resistance point, it is at 15.56.
Ratios To Look Out For
It is important to note that Alto Neuroscience Inc. [NYSE:ANRO] has a current ratio of 19.85. Further, the Quick Ratio stands at 19.85, while the Cash Ratio is 19.62.
Transactions by insiders
Recent insider trading involved Savitz Adam, CHIEF MEDICAL OFFICER, that happened on Jul 09 ’24 when 12069.0 shares were purchased. CHIEF MEDICAL OFFICER, Savitz Adam completed a deal on Jul 10 ’24 to buy 2931.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Smith Nicholas Conrad bought 6150.0 shares on Mar 28 ’24.
